NCT00850304View on ClinicalTrials.gov

Treatment of Non Promyelocytic Acute Myeloid Leukaemia on Elderly Patients by Low Dose Cytosar Plus Arsenic Trioxide

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Leukemia, Myeloid, Acute
Interventions
DRUG

Cytosar

Cytosar 20 mg /q12h/ sc/10d/q28d for 2 cycle

DRUG

Arsenic trioxide

Arsenic trioxide 10mg/infusion2h/iv/DW5% d1-d5,d7-d11

Trial Locations (1)

14114

Hematology-Oncology and SCT Research Center, Tehran

All Listed Sponsors
lead

Tehran University of Medical Sciences

OTHER

NCT00850304 - Treatment of Non Promyelocytic Acute Myeloid Leukaemia on Elderly Patients by Low Dose Cytosar Plus Arsenic Trioxide | Biotech Hunter | Biotech Hunter